These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34418302)
1. A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers. Armstrong DG; Orgill DP; Galiano RD; Glat PM; DiDomenico LA; Carter MJ; Zelen CM Int Wound J; 2022 May; 19(4):791-801. PubMed ID: 34418302 [TBL] [Abstract][Full Text] [Related]
2. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers. Armstrong DG; Galiano RD; Orgill DP; Glat PM; Carter MJ; Di Domenico LA; Reyzelman AM; Zelen CM Int Wound J; 2022 May; 19(4):932-944. PubMed ID: 35080127 [TBL] [Abstract][Full Text] [Related]
3. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial. Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794 [TBL] [Abstract][Full Text] [Related]
4. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial. Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM Int Wound J; 2022 Aug; 19(5):1197-1209. PubMed ID: 35001559 [TBL] [Abstract][Full Text] [Related]
5. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers. Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197 [TBL] [Abstract][Full Text] [Related]
6. Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial. Lantis JC; Snyder R; Reyzelman AM; Van Gils CC; Sigal F; Vayser D; Caporusso JM; Cazzell S; Lavery LA; J Wound Care; 2021 Jul; 30(Sup7):S18-S27. PubMed ID: 34256588 [TBL] [Abstract][Full Text] [Related]
7. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000 [TBL] [Abstract][Full Text] [Related]
8. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients. DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528 [TBL] [Abstract][Full Text] [Related]
9. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial. Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial. Snyder R; Nouvong A; Ulloa J; Wahab N; Treadwell T; Bruwer F; Naude L; McGuire J; Reyzelman AM; Graham T; ; Lessing R; Lullove E; Ozker E; Pham HT; Pasternac M; Cohen S J Wound Care; 2024 Sep; 33(9):688-700. PubMed ID: 39287414 [TBL] [Abstract][Full Text] [Related]
11. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers. Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926 [TBL] [Abstract][Full Text] [Related]
12. Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft. Gould LJ; Orgill DP; Armstrong DG; Galiano RD; Glat PM; Zelen CM; DiDomenico LA; Carter MJ; Li WW Int Wound J; 2022 May; 19(4):811-825. PubMed ID: 34469077 [TBL] [Abstract][Full Text] [Related]
13. A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing. Al-Jalodi O; Kupcella M; Breisinger K; Serena TE Int Wound J; 2022 Nov; 19(7):1838-1842. PubMed ID: 35437881 [TBL] [Abstract][Full Text] [Related]
14. Wound Conforming Matrix Containing Purified Homogenate of Dermal Collagen Promotes Healing of Diabetic Neuropathic Foot Ulcers: Comparative Analysis Versus Standard of Care. Chandler LA; Alvarez OM; Blume PA; Kim PJ; Kirsner RS; Lantis JC; Marston WA Adv Wound Care (New Rochelle); 2020 Feb; 9(2):61-67. PubMed ID: 31903299 [No Abstract] [Full Text] [Related]
15. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial. Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897 [TBL] [Abstract][Full Text] [Related]
16. A single arm prospective feasibility study evaluating wound closure with a unique wearable device that provides intermittent plantar compression and offloading in the treatment of non-healing diabetic foot ulcers. Armstrong DG; Orgill DP; Glat PM; Galiano RD; Rasor ZL; Isaac A; Carter M; Zelen CM Int Wound J; 2023 Mar; 20(3):853-860. PubMed ID: 36054243 [TBL] [Abstract][Full Text] [Related]
17. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers. Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012 [TBL] [Abstract][Full Text] [Related]
18. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers. Driver VR; Reyzelman A; Kawalec J; French M Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266 [TBL] [Abstract][Full Text] [Related]
19. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial. Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262 [TBL] [Abstract][Full Text] [Related]